Thomas J. Doyle

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

Richard Zuniga, Roy Torcuator, Rajan Jain et al. · Journal of Neuro-Oncology · 2008 · 275 citations

Medicine, Oncology, Pharmacotherapy +11

Gene Therapy Restores Vision-Dependent Behavior as Well as Retinal Structure and Function in a Mouse Model of RPE65 Leber Congenital Amaurosis

Jijing Pang, Bo Chang, Ashok Kumar et al. · Molecular Therapy · 2005 · 198 citations

Medicine, Genetics, Molecular Biology +17

The Salmonella typhimurium virulence plasmid increases the growth rate of salmonellae in mice

Paul A. Gulig, Thomas J. Doyle · Infection and Immunity · 1993 · 194 citations · Full text

Life Sciences, Genetics, Microbiology +14

Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis

Roy Torcuator, Richard Zuniga, Yedathore S. Mohan et al. · Journal of Neuro-Oncology · 2009 · 192 citations

Medicine, Oncology, Radiation Oncology +13